• Resilience Bolsters Canadian Biomanufacturing Site contractpharma
    May 24, 2021
    ​National Resilience, Inc., said that the Government of Canada will invest $163.8 million, through the Strategic Innovation Fund, in the company’s Ontario-based subsidiary Resilience Biotechnologies Inc. (RBI) to modernize and expand production capacity.
  • Resilience Acquires Ology Bioservices contractpharma
    April 20, 2021
    ​National Resilience, Inc., a company that says it is building a biopharmaceutical manufacturing ecosystem, has acquired Ology Bioservices, a privately held company that also specializes in biologic drug substance manufacturing from early stage ...
PharmaSources Customer Service